Vitamin D has garnered much research and debate about supplementation in recent years, not only as it pertains to patients with kidney disease but also to those in the general population. This review discusses observational and available clinical trial evidence about the effects of both calcitriol and vitamin D analogs (active) and ergo-calciferol and cholecalciferol (nutritional) vitamin D in patients with CKD and ESRD.
|Number of pages
|Clinical Journal of the American Society of Nephrology
|Published - Feb 1 2012
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine